<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05101031</url>
  </required_header>
  <id_info>
    <org_study_id>20-2845</org_study_id>
    <nct_id>NCT05101031</nct_id>
  </id_info>
  <brief_title>Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)</brief_title>
  <acronym>Fresh-ER</acronym>
  <official_title>Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ivor Douglas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Denver Health and Hospital Authority</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to observe the change in hemodynamic variables (i.e. CO, SV,&#xD;
      HR, SV) as assessed during rapid fluid bolus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Noninvasive Starling SV (Baxter Healthcare) is a portable, non-invasive, cardiac output&#xD;
      detector system. The Starling SV system measures the cardiac output by employing electrical&#xD;
      bioreactance. Bioreactance is a measure of the electrical characteristics of a volume of&#xD;
      tissue and fluid. In the case of cardiac output measurements, the relevant tissue includes&#xD;
      the heart and the immediate surrounding volume of the thorax. The relevant fluid is blood.&#xD;
&#xD;
      The objective of the study is observe the change in hemodynamic variables (i.e. CO, SV, HR,&#xD;
      SV) as assessed during the initial resuscitation of 30 ml/kg of fluid, to evaluate the&#xD;
      feasibility of performing a larger prospective RCT of SV-guided resuscitation in patients who&#xD;
      undergo a dynamic assessment of fluid responsiveness to help guide fluid administration.&#xD;
&#xD;
      This study is a prospective feasibility study. Patients will be evaluated by the Emergency&#xD;
      Room team for Inclusion/Exclusion criteria. If the patient is found to fit the study&#xD;
      inclusion and exclusion criteria, then the fully non-invasive Starling monitor will be&#xD;
      applied to the patient and the patient's hemodynamic data will be prospectively collected&#xD;
      during the initial fluid resuscitation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 18, 2020</start_date>
  <completion_date type="Anticipated">December 17, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 17, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke Volume Change</measure>
    <time_frame>During fluid bolus</time_frame>
    <description>Change in stroke volume following the administration of each 500 cc fluid bolus.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke Volume Difference</measure>
    <time_frame>during fluid bolus</time_frame>
    <description>Concordance between change in stroke volume compared between fluid bolus and other usual care assessments of effective circulating volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid Input and Output</measure>
    <time_frame>72 hours</time_frame>
    <description>Fluid balance inclusive of all parenteral fluids and all output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LOS in ICU</measure>
    <time_frame>Up to 180 days from ICU admission</time_frame>
    <description>Length of ICU stay (days) until subject is medically ready for discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation</measure>
    <time_frame>28 days</time_frame>
    <description>Requirement for mechanical ventilation during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor Use</measure>
    <time_frame>28 days</time_frame>
    <description>Requirement for vasopressor use during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Creatinine Levels</measure>
    <time_frame>28 days</time_frame>
    <description>Changes in serum creatinine levels from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Replacement Therapy</measure>
    <time_frame>28 days</time_frame>
    <description>Requirement for renal replacement therapy (RRT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>28 days</time_frame>
    <description>Incidence of Major Adverse Cardiac Event (MACE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>28 days</time_frame>
    <description>Incident of Adverse Events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Inhospital Mortality rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge Location</measure>
    <time_frame>Up to 180 days from hospital admission</time_frame>
    <description>Discharge location after hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid Input and Output in ICU</measure>
    <time_frame>28 days</time_frame>
    <description>Mean difference in fluid balance at ICU discharge</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Undifferentated Shock</condition>
  <arm_group>
    <arm_group_label>Denver Health Medical Center</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Oregon Health and Science University</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Starling SV</intervention_name>
    <description>The Starling SV will monitor the change in hemodynamic variables (i.e. CO, SV, HR, SV) as assessed during the initial fluid resuscitation in individuals with hypotension related to infection.</description>
    <arm_group_label>Denver Health Medical Center</arm_group_label>
    <arm_group_label>Oregon Health and Science University</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be drawn from all patients who undergo present to the Emergency&#xD;
        Room with symptoms of suspected or confirmed septic shock, and who are identified to&#xD;
        receive a 30cc/kg fluid bolus of resuscitation fluid as part of treatment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Primary Criteria&#xD;
&#xD;
          1. MAP &lt;65&#xD;
&#xD;
          2. SBP &lt;90 or BP rapidly trending lower&#xD;
&#xD;
             Secondary Criteria&#xD;
&#xD;
          3. Low urine output Acute change in urine output less than 50ml/4 hours&#xD;
&#xD;
          4. Persistent hyperlactatemia&#xD;
&#xD;
          5. A new vasopressor started&#xD;
&#xD;
          6. Acute change in HR less than 50 or greater than 120&#xD;
&#xD;
          7. New onset chest pain or chest pain different then admission assessment&#xD;
&#xD;
          8. Acute bleeding&#xD;
&#xD;
          9. Fever &gt; 39 degrees&#xD;
&#xD;
         10. Significant change in mental status: confusion, agitation, delirium, etc.&#xD;
&#xD;
         11. Unexplained lethargy&#xD;
&#xD;
         12. CRT &gt;2 seconds -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Primary diagnosis of: acute cerebral vascular event, acute coronary syndrome, acute&#xD;
             pulmonary edema, status asthmatics, major cardiac arrhythmia, drug overdose, or injury&#xD;
             from burn or trauma&#xD;
&#xD;
          2. Known aortic insufficiency, or aortic abnormalities&#xD;
&#xD;
          3. Requires immediate surgery&#xD;
&#xD;
          4. Advanced directives restricting implementation of the resuscitation protocol&#xD;
&#xD;
          5. Known intraventricular heart defect, such as VSD or ASD&#xD;
&#xD;
          6. Prisoner&#xD;
&#xD;
          7. Pregnancy&#xD;
&#xD;
          8. Age &lt;18&#xD;
&#xD;
          9. Known allergy to sensor material or gel&#xD;
&#xD;
         10. Suspected intra-abdominal hypertension&#xD;
&#xD;
         11. Inability to obtain IV access&#xD;
&#xD;
         12. Patient should be excluded based on the opinion of the Clinician/Investigator&#xD;
&#xD;
         13. Patient has an unstable airway&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivor Douglas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Denver Health Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Denver Health Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Monnet X, Teboul JL. Passive leg raising. Intensive Care Med. 2008 Apr;34(4):659-63. doi: 10.1007/s00134-008-0994-y. Epub 2008 Jan 23.</citation>
    <PMID>18214429</PMID>
  </reference>
  <results_reference>
    <citation>Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013 Jul;41(7):1774-81. doi: 10.1097/CCM.0b013e31828a25fd.</citation>
    <PMID>23774337</PMID>
  </results_reference>
  <results_reference>
    <citation>Michard F, Teboul JL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest. 2002 Jun;121(6):2000-8. Review.</citation>
    <PMID>12065368</PMID>
  </results_reference>
  <results_reference>
    <citation>Kelm DJ, Perrin JT, Cartin-Ceba R, Gajic O, Schenck L, Kennedy CC. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock. 2015 Jan;43(1):68-73. doi: 10.1097/SHK.0000000000000268.</citation>
    <PMID>25247784</PMID>
  </results_reference>
  <results_reference>
    <citation>Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011 Feb;39(2):259-65. doi: 10.1097/CCM.0b013e3181feeb15.</citation>
    <PMID>20975548</PMID>
  </results_reference>
  <results_reference>
    <citation>Vincent et al. Sepsis in European ICU: Results of the SOAP study. British Journal of Anesthesia 2006; 113: 740-747.</citation>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 22, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Denver Health and Hospital Authority</investigator_affiliation>
    <investigator_full_name>Ivor Douglas</investigator_full_name>
    <investigator_title>Chief of Pulmonary and Medical Critical Care</investigator_title>
  </responsible_party>
  <keyword>Resuscitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

